34518515|t|Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy.
34518515|a|IL6 is one of the most elevated cytokines during chimeric antigen receptor (CAR) T cell cytokine release syndrome (CRS), and IL6R blockade by Tocilizumab has successfully relieved the most life-threatening aspects of CRS in patients. In addition, latest studies demonstrated the essential role of IL1 in driving CART induced neurotoxicity in mouse models. Here we present a clinical investigation (ChiCTR2000032124; ChiCTR2000031868) of anti-CD19 and anti-BCMA CART (41BBzeta) secreting an anti-IL6 scFv and IL1 receptor antagonist (IL1RA) in treating patients with hematologic malignancy. Our results revealed that IL6 and IL1B were maintained at low levels without significant elevation during CRS, rendering Tocilizumab dispensable. Moreover, treated patients did not show neurotoxicity during CRS and exhibited mild to moderate CRS. Notably, we observed high rate of complete response (CR) and significant CART expansion during treatment. In sum, we conclude that CART-secreting anti-IL6 scFv and IL1RA could self-neutralize IL6 storm and maintain low levels of IL1B during CART therapy to minimize IL6- and IL1-associated cytokine toxicity and neurotoxicity without impairing therapeutic efficacy.
34518515	0	25	Chimeric antigen receptor	Gene	9970
34518515	52	55	IL6	Gene	3569
34518515	65	73	patients	Species	9606
34518515	79	101	hematologic malignancy	Disease	MESH:D019337
34518515	103	106	IL6	Gene	3569
34518515	152	177	chimeric antigen receptor	Gene	9970
34518515	179	182	CAR	Gene	9970
34518515	191	216	cytokine release syndrome	Disease	MESH:D000080424
34518515	218	221	CRS	Disease	MESH:D000080424
34518515	228	232	IL6R	Gene	3570
34518515	245	256	Tocilizumab	Chemical	MESH:C502936
34518515	320	323	CRS	Disease	MESH:D000080424
34518515	327	335	patients	Species	9606
34518515	400	403	IL1	Gene	111343
34518515	415	419	CART	Gene	27220
34518515	428	441	neurotoxicity	Disease	MESH:D020258
34518515	445	450	mouse	Species	10090
34518515	545	549	CD19	Gene	930
34518515	559	563	BCMA	Gene	608
34518515	564	568	CART	Gene	9607
34518515	598	601	IL6	Gene	3569
34518515	655	663	patients	Species	9606
34518515	669	691	hematologic malignancy	Disease	MESH:D019337
34518515	719	722	IL6	Gene	3569
34518515	727	731	IL1B	Gene	3553
34518515	799	802	CRS	Disease	MESH:D000080424
34518515	814	825	Tocilizumab	Chemical	MESH:C502936
34518515	857	865	patients	Species	9606
34518515	879	892	neurotoxicity	Disease	MESH:D020258
34518515	900	903	CRS	Disease	MESH:D000080424
34518515	935	938	CRS	Disease	MESH:D000080424
34518515	1013	1017	CART	Gene	9607
34518515	1071	1075	CART	Gene	9607
34518515	1091	1094	IL6	Gene	3569
34518515	1132	1135	IL6	Gene	3569
34518515	1169	1173	IL1B	Gene	3553
34518515	1181	1185	CART	Gene	9607
34518515	1206	1209	IL6	Gene	3569
34518515	1215	1218	IL1	Gene	3553
34518515	1239	1247	toxicity	Disease	MESH:D064420
34518515	1252	1265	neurotoxicity	Disease	MESH:D020258
34518515	Association	MESH:D019337	9970
34518515	Association	MESH:D064420	3553
34518515	Association	MESH:D020258	111343
34518515	Association	MESH:D000080424	9970
34518515	Association	MESH:D000080424	9607
34518515	Negative_Correlation	3569	9607
34518515	Association	MESH:D019337	9607
34518515	Association	MESH:D020258	3553
34518515	Association	MESH:D064420	9607
34518515	Association	MESH:D064420	3569
34518515	Positive_Correlation	MESH:D020258	27220
34518515	Association	MESH:D020258	9607
34518515	Association	MESH:D020258	3569
34518515	Negative_Correlation	MESH:C502936	3570
34518515	Association	MESH:D000080424	3569
34518515	Association	MESH:D019337	3569
34518515	Association	111343	27220
34518515	Negative_Correlation	27220	3569
34518515	Association	3553	9607
34518515	Negative_Correlation	MESH:C502936	MESH:D000080424
34518515	Positive_Correlation	3569	9970
34518515	Association	MESH:D000080424	3570

